Related Experiment Videos

Photochemotherapy: identification of a metabolite of 4, 5', 8-trimethylpsoralen

B B Mandula, M A Pathak, G Dudek

Science (New York, N.Y.)

|September 17, 1976

Abstract:

A compound, 4, 8-dimethyl, 5'-carboxypsoralen (DMeCP), has been identified in mouse urine as a major metabolite of the photoactive drug, 4, 5', 8-trimethylpsoralen (TMeP). This drug is widely used in the treatment of vitiligo and psoriasis. DMeCP is fluorescent, and nonphotosensitizing when tested on guinea pig skin. DMeCP also occurs in the urine of human patients receiving TMeP orally.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.

The Journal of investigative dermatology·2010

Dietary lutein/zeaxanthin partially reduces photoaging and photocarcinogenesis in chronically UVB-irradiated Skh-1 hairless mice.

Skin pharmacology and physiology·2007

An extract of Polypodium leucotomos appears to minimize certain photoaging changes in a hairless albino mouse animal model. A pilot study.

Photodermatology, photoimmunology & photomedicine·1999

Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin.

Photodermatology, photoimmunology & photomedicine·1997

Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos.

Photodermatology, photoimmunology & photomedicine·1996

An unusual case of lung torsion.

Chest·1995

See all related articles